• Recent
  • Class
  • Inventors
  • Assignees
  • Top Lists
  • Pricing
  • Account
Patents-Review.com
  1. Home
  2. Inventor
  3. C
  4. Cou…
  5. COUFFINHAL Thierry
🔗 Permalink
Inventor profile of:

Thierry COUFFINHAL

City:

Pessac

Country:

France

Published Applications:

4

Last publication date:

2026-02-26

Recent patent applications by COUFFINHAL Thierry

Thierry COUFFINHAL from Pessac, FR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-02-26
US20260053777A1
Human necessities

USE OF NRF2 ACTIVATORS FOR THE TREATMENT OF CEREBRAL SMALL VESSEL DISEASE

#2 | 2023-01-19
US20230017666A1
Chemistry; metallurgy

AN UBIQUITIN LIGASE INHIBITOR FOR USE FOR PREVENTING AND/OR TREATING A DISEASE LINKED WITH CEREBRAL HYPOPERFUSION

#3 | 2022-12-08
US20220387408A1
Human necessities

USE OF MAST CELL STABILIZER FOR THE TREATMENT OF HEART FAILURE WITH PRESERVED EJECTION FRACTION

#4 | 2020-03-19
US20200087403A1
Chemistry; metallurgy

PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF THROMBOSIS IN PATIENTS SUFFERING FROM A MYELOPROLIFERATIVE NEOPLASM

InventorID:

2676341 ⎘

  1. Home
  2. Inventor
  3. C
  4. Cou…
  5. COUFFINHAL Thierry

Some parts © 2022-2026 Patents-Review.com

Browse & Discovery
  • Home
  • Patent Classification
  • Inventor Index
  • Assignee Index
  • Interesting Applications
Search & Tools
  • Basic Search
  • Advanced Search
  • Patent Alerts
  • Top Lists
  • Statistics
Information & Resources
  • About US Patent System
  • Terms & Privacy
  • Pricing
  • Contact
Quick Access
  • Latest Applications
  • Top Inventors 2026
  • Top Assignees 2026
  • Featured Patents
Disclaimer: This website is intended for informational purposes only, and its content is based on public patent records. Please note that some sections of this website have been created or processed using machine learning models. We provide content in good faith but make no guarantees regarding accuracy or completeness. By using this site, you accept any risks and waive claims against us for errors or omissions.